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ABSTRACT 
The control of visceral leishmaniasis caused by Leishmania donovani 
still remains a challenging problem. Due to limitations of available 
therapies, search for new antileishmanial agents becomes necessary. 
India, being rich in traditional medicinal plant species, provides good 
opportunity for exploration of new, effective and safe 
antileishmanials.  The seeds of Abutilon indicum, a herbaceous plant 
commonly known as Thuthi and used as a remedy for jaundice, piles, 
ulcer and leprosy, were evaluated for the first time for its 
antileishmanial activity.  The crude methanolic extract and two of its 
four fractions - n-hexane and n-butanol were found to be highly 
active against Leishmania promastigotes and intracellular 
amastigotes. When administered orally to L. donovani infected 
hamsters the extract and its two fractions at a dose of 500 mg/kg x5 
days exhibited ~75% efficacy. The results suggested towards the 
potentiality of this plant’s seeds as a source of new antileishmanial 
leads for further investigations. 
Keywords: Abutilon indicum, Antileishmanial efficacy, Leishmania 
donovani; Amastigote, Macrophage, Hamster. 
INTRODUCTION 
Visceral leishmaniasis (VL) caused 
by protozoan parasite Leishmania donovani 
is regarded as a major public health problem 
causing significant morbidity and mortality 
in tropical and sub-tropical countries. First-
line treatment for VL is dependent on an age 
old pentavalent antimonials against which 
Indian sub-continent has witnesses a marked 
unresponsiveness as upto 65% treatment 
failures were observed in Bihar state of 
India. Other drugs, amphotericin B 
desoxycholate and liposomal amphotericin 
B in use were however, expensive and cause 
toxicity complications. Recently two new 
drugs, Miltefosine and Paromomycin were 
registered for VL treatment in India and in 
spite of their excellent efficacy the 
possibility of emergence of resistance 
against these drugs has remained1.  
 
 
 
Address for 
Correspondence 
Division of 
Parasitology, Central 
Drug Research 
Institute 
New Campus, BS 10/1, 
Sector 10, Jankipuram 
Vistar, Lucknow- 
226031       
 E-mail: 
anuradha_dube 
@rediffmail.com 
 Dube et al__________________________________________________ ISSN 2321 – 2748 
AJPCT[2][1][2014]134-139  
In recent years, there has been 
growing interest in the use of plants derived 
natural products and India being rich in 
traditional medicinal plant species, provides 
good opportunity to explore them in a search 
of new, effective and safe antileishmanial 
compounds. Abutilon indicum belonging to 
the family Malvaceae is commonly known 
as Thuthi and has been used in the Siddha 
system of medicine as a remedy for 
jaundice, piles, ulcer and leprosy2. The plant 
grows as a weed and is found abundantly in 
wasteland from the seashore to 2000 meters 
high in India, and in sub Himalayan tracks3. 
It is a herbaceous or shrubby, softly 
tomentose plant and its stems are round 
often tinged with purple colour. It is not a 
poisonous plant and there is no report of any 
adverse effects. Its roots are used as diuretic 
and for leprosy; leaves for ulcers, headaches, 
gonorrhea & bladder infection. A. indicum 
having β-sitosterol isolated from the 
petroleum ether extract of leaf of showed 
mosquito larvicidal activity4. The plant 
possesses analgesic activity5 and in some 
places, juice from leaves of this plant is used 
in combination with the liquid extract of 
Allium cepa to treat jaundice and liver 
disorders. The plant has also been reported 
to possess antibacterial activity against gram 
positive bacteria Bacillus cereus, 
Staphylococcus aureus and gram negative 
bacteria Klebsiella pneumoniae, Escherichia 
coli6. In this communication we have for the 
first time explored seed extracts of this plant 
for its antileishmanial potential.  
 
MATERIALS AND METHODS 
Plant Material 
A. indicum seeds were collected from 
Regional Research Laboratory campus, 
Bhuvaneshwar, Orissa, India in February, 
2006, and identified by Division of Botany, 
Central Drug Research Institute. Voucher 
specimen (No.8507) is kept in the herbarium 
of the institute.  
Extraction and Fractionation 
A powdered A. indicum seed (1.7Kg) 
with 95% ethanol (5 L) in a glass percolator 
was allowed to stand at room temperature for 
about 24 h. The percolate was collected. This 
process of extraction was repeated four times. 
The combined extract was filtered, 
concentrated under vacuum using rotavapor at 
40oC and weighed (EE 65 g, 3.82%). This 
ethanolic extract (35g) was partitioned 
successively with n-hexane (200mLx5), 
chloroform (200mLx5) and n-butanol 
saturated with water (200mLx6) affording a 
hexane (F002, 13g) CHCl3 (F003, 7g), n-
butanol (F004, 8g) and aqueous (F005, 6g) 
soluble fractions. 
 
Parasite and Hosts 
L.donovani (Dd8 strain) 
promastigotes were cultured in RPMI-1640 
medium (Sigma, USA) supplemented with 
10% fetal bovine serum (Sigma, USA), 
penicillin (100 U/ml) and streptomycin (100 
g/ml) at 260C. Transgenic parasites 
expressing green fluorescent protein (GFP) 
were maintained in presence of 100 g/ml of 
antibiotic G4187. Mouse macrophage 
adherent cell line J774A.1 was maintained in 
Dulbecco’s modified Eagle’s medium 
(Sigma, USA) supplemented with 10% heat 
inactivated FBS at 37ºC in humidified 
atmosphere with 5% CO2. 
Male golden hamsters (Mesocricetus 
auratus) weighing approximately 50g were 
used as the experimental host in this study. 
Animals were kept in plastic cages in 
climatically controlled rooms and fed with 
standard rodent food pellet (Lipton India, 
Mumbai) and water ad libitum. Infection to 
naive hamsters was established by spleen-
derived amastigotes as per method described 
elsewhere8. The use of animals for all the 
experiments was in compliance with the 
relevant guidelines of the institutional animal 
ethics committee  
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Experimental Protocols 
 
In vitro testing 
For testing against transgenic GFP-
expressing log phase promastigotes, 1×106 
cells/ml were put into 48-well tissue culture 
plates (CellStar) and different concentrations 
of test samples were administered. At 72 h 
after treatment the effect of extract and 
fractions was assessed by flow cytometry as 
described by Dube et al8. Untreated cells 
served as control. The inhibition of parasite 
growth was determined by comparing the 
fluorescence levels of drug-treated parasites 
with control parasites.  
The efficacy was also checked against 
intracellular amastigotes and for this J774A.1 
macrophages (105 cells/well) growing in 24 
well plates were infected with metacyclic 
GFP-promastigotes at 10:1 (parasite 
/macrophage) ratio and incubated at 37°C in 
5% CO2 for 12-24 h. Non-phagocytosed 
parasites were removed by washing and 
finally the wells were supplemented with 
complete medium. At 72 h after treatment, 
cells were washed with PBS, transferred to 
tubes and analyzed by FACS as described 
above. The inhibition of parasite growth was 
determined by comparing the fluorescence 
levels of drug-treated infected MQs with that 
of untreated infected MQs. Miltefosine was 
used as a reference antileishmanial drug 
against both the stages. Each assay was 
performed in triplicate. 
 
In vivo testing 
Antileishmanial activity of seeds of A. 
indicum against L.donovani was assessed in 
vivo at different doses by oral route (p.o.). 
Twenty five day old L.donovani infected 
hamsters were subjected to splenic biopsy to 
estimate the initial parasite load. Thereafter 
the animals were divided into groups of 3 
animals each and the treatment was initiated 
in one group at a dose level of 500mg/kg and 
continued for 5 consecutive days. The second  
group of animals was treated orally with the 
reference drug - Miltefosine at a dose of 
40mg/kg×5. Third group served as untreated 
control. Splenic biopsies were performed on 
days 7 and 28 p.t. and the percent inhibition 
was assessed using the formula as described 
elsewhere8. The other doses of test samples 
were also tested to obtain optimum efficacy. 
 
Assessment of NO activity 
The presence of NO was assessed 
using Griess reagent in the culture 
supernatants of macrophage cell lines 
(J774.1). LPS (10ug/ml Sigma, USA) was 
used as mitogen. Cultured macrophages were 
suspended in culture medium and plated at 
106cells/well and exposed to the methanolic 
extract and fractions of above described from 
all the study groups. The supernatants (100 
ul) collected from macrophage cultures 24 h 
after incubation was mixed with an equal 
volume of Griess reagent (Sigma, USA) and 
left for 10 min at room temperature. The 
absorbance of the reaction was measured at 
540nm in an ELISA reader9. 
 
Statistical Analysis 
Two to three replicates were done in 
case where activity was observed for 
confirmation and results were expressed as 
mean ± SD. Statistical analyses were 
performed using Graphpad prism software. 
 
RESULTS AND DISCUSSION 
In a bid to explore those plant species 
which are commonly used in traditional 
herbal medicine for treating various parasitic 
diseases for their antileishmanial potential, 
A.indicum was taken as it was reported to 
possess various pharmacological activities. In 
this study we have assessed the 
antileishmanial activity of the seeds of this 
plant. The ethanol extract of the seeds of A. 
indicum as well as two of its fractions, n-
hexane fraction and n-butanol fraction have 
exhibited dose-dependent antileishmanial 
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activity against promastigote and intracellular 
amastigote forms of L.donovani in vitro. The 
crude extract exhibited 94.3±6.9% and 
78.2±5.5% efficacy against Leishmania 
promastigote and intracellular amastigotes, 
respectively, at 100 μg/ml concentration 
(Table 1). At a lower dose of 50 μg/ml, it 
demonstrated 57.6%±5.1% and 49.7±6.2% 
efficacy against promastigotes and 
intracellular amastigotes respectively. Among 
the fractions, n-Hexane fraction was the most 
potent resulting in 90.3±7.4% and 72.2±6.4% 
efficacy against promastigotes and 76.7±3.7% 
and 54.4±4.2% efficacy against amastigotes 
at 100- and 50μg/ml concentrations followed 
by n-butanol fraction (89.1±7.7% and 
67.8±8.4% efficacy against promastigotes and 
69.6±6.4%and 46.23±5.2% efficacy against 
amastigotes) at respective concentrations of 
100 and 50μg/ml. Chloroform and aqueous 
fractions were inactive against both the stages 
of the parasite (Table-1). Good 
antileishmanial activity of this plant against 
clinical relevant (amastigote) stage is 
encouraging.  
NO are firmly established to play a 
role as antimicrobial effector molecules 
produced by activated Ms10,11, hence its 
production in J774.1 macrophage was studied 
after 24 h of incubation in the presence of 
extract and fractions. For comparison, NO 
production in mitogenic (LPS) stimulated and 
untreated cells served as positive and negative 
controls respectively (Fig.1). NO production 
was recorded to be higher in n-hexane 
fraction (22.9µM±0.13) at 100g/ml which 
was very close to mitogen (LPS) stimulated 
NO (23.9 µM±0.71) production and exhibited 
significantly more than 2-fold increase when 
compared with untreated cells. Treatment 
with methanol extract and other fractions viz 
n-butanol, chloroform and aqueous fraction at 
100 g/ml were lesser effective in stimulating 
NO production (Fig.1). These findings 
substantially increased the NO production in 
Ms confirms their NO enhancing ability.  
The activity of the potential 
extracts/fractions was further tested in 
L.donovani infected hamsters. Ethanol extract 
exhibited dose-dependent efficacy with 
highest activity being observed at an initial 
dose of 500 mg/kg x5 days to the tune of 
74.4±7.4% inhibition of parasite 
multiplication. Among the fractions tested at 
250-mg/kg dose the n-hexane fraction showed 
superior antileishmanial efficacy 76.4±7.1 
followed by n-butanol fraction 71.3±8.1%. 
This indicates that the active principles are 
concentrated in these fractions. The efficacy 
of n-butanol was similar to methanol extract. 
The chloroform and aqueous fractions were 
totally inactive. Miltefosine, the reference 
drug, exhibited 94.0±2.3% inhibition at a 40-
mg kg−1 day−1×5 dose (Fig. 1).These 
findings further substantiate the in vitro 
observations.   
On the basis of these results, it is very 
clear that apart from the aerial part of A. 
indicum its seeds also possess potential which 
may provide promising leads for the 
development of new drugs against 
leishmaniasis. This is a preliminary report and 
further studies are needed to elucidate the 
pure chemical entities of n-hexane fraction of 
the seeds for its antileishmanial efficacy. 
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Table 1. Antileishmanial effect of extract and fractions of Abutilon indicum against Leishmania 
donovani promastigotes and intracellular amastigotes. Data (mean  standard deviation) 
represents results of three independent experiments 
 
Plant extract and 
fractions 
Activity against promastigotes Activity in 
MQ -amastigote system 
Dose 
(g/ml) 
% Inhibition 
(Mean  S.D.) Dose (g/ml) 
% Inhibition 
(Mean  S.D.) 
Ethanol extract (EE) 
100 
50 
94.3  6.9 
57.6  5.1 
100 
50 
78.2±5.5 
49.7±6.2 
n-Hexane fraction 
(F002) 
100 
50 
90.3  7.4 
72.2  6.4 
100 
50 
76.7±3.7 
54.4±4.2 
Chloroform fraction 
(F003) 
100 
50 
NI* 
NI 
100 
50 
NI 
NI 
n-Butanol fraction 
(F004) 
100 
50 
89.1  7.7 
67.8  8.4 
100 
50 
69.6±6.4 
46.23±5.2 
Aqueous fraction (F005) 
100 
50 
NI 
NI 
100 
50 
NI 
NI 
Miltefosine 
10 
5 
100 
100 
10 
5 
100 
64.3  6.8 
* NI = No inhibition, $ Ms = Macrophages 
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Figure 1. :(A) NO generation in J774 macrophages by extract and fractions of Abutilon 
indicum. Cells pretreated with test samples (50g/ml and 100 g/ml) were analysed by 
griess reagent Data represent the mean ± SD of three separate experiments; (B) In vivo 
efficacy of Abutilon indicum ethanol extract against established infection of Leishmania 
donovani in golden hamsters. Results are expressed as mean ± SD of three separate 
experiments 
